Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Launch Activist Tag-Team Attack On Struggling Industrial Supplier

Page 1 of 2

A new 13D filing with the SEC discloses that Coppersmith Capital Management, co-founded by its managing partner Jerome Lande, holds an ownership stake of nearly 1.43 million shares in Itron Inc. (NASDAQ:ITRI). More importantly, the freshly-disclosed filing also reveals that Coppersmith Capital has teamed up with Scopia Capital Management, founded by Matt Sirovich and Jeremy Mindich, to disclose a group stake of 2.35 million shares of Itron, which account for 6.2% of its outstanding shares. The freshly-formed group is set to engage in discussions with the company’s Board of Directors in an attempt to unlock shareholder value. The 1.43 million share-stake represents a new position for Coppersmith Capital, while the other investment firm has not made any transactions related to Itron over the past 60 days. Meanwhile, the shares of Itron have surged by over 4% in today’s trading session on the news.

Jeremy Mindich - Scopia Capital

Prior to diving into the content of the 13D filing submitted on behalf of both Coppersmith Capital Management and Scopia Capital, we will provide a brief overview of the two investment firms. Coppersmith Capital Management is an activist hedge fund co-established by Jerome Lande in 2012. The investment firm is primarily focused on event-driven investing, in undervalued small and mid-cap companies. As stated by its most recent 13F filing with the SEC, Coppersmith Capital manages a public equity portfolio worth $95.03 million as of June 30. Moving on to the other investment firm discussed in this article, Scopia Capital Management is an alternative asset management firm founded by Matt Sirovich and Jeremy Mindich back in 2001. The New York-based investment firm employs a value-driven investment approach across four different strategies. Scopia Capital has over $5 billion of assets under management, and manages a public equity portfolio with a market value of $5.15 billion as of the end of June.

Matt Sirovich And Jeremy Mindich
Matt Sirovich And Jeremy Mindich
Scopia Capital

Professional investors like Jerome Lande spend considerable time and money conducting due diligence on each company they invest in, which makes them the perfect investors to emulate. However, we also know that the returns of hedge funds on the whole have not been good for several years, underperforming the market. We analyzed the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better than their large-cap picks, which is where most of their money is invested and why their performances as a whole have been poor. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic the best ideas of the best fund managers on your own? A portfolio consisting of the 15 most popular small-cap stock picks among the funds we track has returned 118% and beaten the market by more than 60 percentage points since the end of August 2012 (see the details).

Jerome Lande And Craig Rosenblum
Jerome Lande And Craig Rosenblum
Coppersmith Capital

Let’s now move on to the target of the two investment firms’ activist campaign. Itron Inc. (NASDAQ:ITRI) is a technology company that provides end-to-end smart metering solutions to electric, natural gas, and water utilities. The tech company’s stock performance has been very poor in 2015, considering that its shares have lost over 26% since the beginning of the year. At the same time, the stock is not very popular among the hedge funds monitored by our team, with only 16 money managers invested in Itron at the end of the second quarter, compared to 18 registered in the prior one. Besides the aforementioned shareholders, Ian Simm’s Impax Asset Management and Jim Simons’ Renaissance Technologies are two bullish hedge funds on Itron, holding 1.23 million shares and 427,961 shares, respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!